June 03, 2013 at 09:55 AM EDT
Morning Market Losers
Synta Pharmaceuticals (NASDAQ: SNTA ) shares dipped 32.93% to $4.95 after the company reported positive overall survival results from GALAXY-1 Phase 2b/3 trial of ganetespib in second-line non-small cell lung cancer. Infinity Pharmaceuticals (NASDAQ: INFI ) shares lost 23.41% to $20.64 on Phase 1 data. Affymax (NASDAQ:
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here